Zymewire Blog

Exploring the frontiers of biotech & pharma.

Join us as we dive into the sea of emerging biotechs, discuss industry news and the implications they have on providers to biopharma (CROs, CDMOs, eClinical, etc.), and tips for prospecting within the everchanging world of life sciences. 

OUR LATEST

Zymewire Blog

Why Your Cold Outreach to Biotechs (Still) isn't Working: A Battle with AI

06 Mar, 2024
Goals & Hurdles Read More

Rectangle 10

Subscribe Now

Rectangle 10

Recent Posts

A Letter to the COVID Collaborators
A Letter to the COVID Collaborators
13 Jun, 2023
Zymewire News
by Alec de la Durantaye

Thinking back to the first half of 2020 often causes a mixed wave of emotions to resurface. At the time, society as a whole shared an ...

Read More
Biopharma Funding Year in Review
Biopharma Funding Year in Review
26 Jan, 2023
Zymewire News
by Ian Hamilton-Burge, Director of Customer Solutions

Review of 2022 Biopharma funding: How should sales teams at service providers adapt for 2023?

Read More
Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon
Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon
04 Jan, 2023
Zymewire News
by Alec de la Durantaye

Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon

Read More
More Signal, Less Noise: Announcing Muting Companies in Zymewire
More Signal, Less Noise: Announcing Muting Companies in Zymewire
12 Oct, 2022
Zymewire News
by Ian Hamilton-Burge, Director of Customer Solutions

Noise is a Problem, Turn Down the Volume.

Read More
Reach your prospects the first time: Announcing improvements to Contact Search
Reach your prospects the first time: Announcing improvements to Contact Search
14 Feb, 2022
Zymewire News
by Ian Hamilton-Burge, Director of Customer Solutions

Laser-focused outreach outperforms generic messages and mass emails. That’s the guiding principle behind our update to Contact Search, ...

Read More
Selling to Biotech After the COVID Cliff
Selling to Biotech After the COVID Cliff
14 May, 2021
Zymewire News
by Casey Enders

Are you wondering how the pandemic will change the biotech landscape and your prospecting work? We were, too – so we dug into the data and ...

Read More
What do big pharma companies spend on research & development?
What do big pharma companies spend on research & development?
01 Apr, 2020
Zymewire News
by Sean Cannon

We've been working hard on a new report, and today we're happy to share that it is now available through Outsourcing-Pharma! Our inaugural ...

Read More
Racolta: Stay up to date on Pharma/Biotech Events
Racolta: Stay up to date on Pharma/Biotech Events
15 Oct, 2019
Zymewire News
by Sean Cannon

A partner of ours, Racolta, recently launched their new website and we would like to share! Subscribers can stay notified of upcoming ...

Read More
CPhI Worldwide 2018
CPhI Worldwide 2018
15 Oct, 2019
Zymewire News
by Sean Cannon

Last week, we had the pleasure of visiting sunny Madrid (at least any other week out of the year it’s supposed to be sunny) for one of ...

Read More
Your market in your pocket
Your market in your pocket
15 Oct, 2019
Zymewire News
by Sean Cannon

It’s one thing to have deep insight into your industry to always know what’s going on with customers, both prospective or existing, but ...

Read More
Keeping things fresh
Keeping things fresh
10 Oct, 2019
Zymewire News
by Sean Cannon

As you may have noticed, things are a little bit different around here. We recently launched a brand new blog website, which will hopefully ...

Read More
Bring out the Grad Attire: Zymewire Completes Creative Destruction Lab
Bring out the Grad Attire: Zymewire Completes Creative Destruction Lab
10 Oct, 2019
Zymewire News
by Sean Cannon

It has been an exciting time for us here at Zymewire as of late. Our team is expanding, we’ve had the chance to meet many new people during ...

Read More

Custom built for biotech and pharma

We are obsessed with finding new ways to help your business generate more qualified leads. Our human-verified AI scans thousands of documents every day, separates the signal from the noise, and delivers value in the form of actionable sales intelligence.